InvestorsHub Logo
Followers 27
Posts 4020
Boards Moderated 0
Alias Born 01/11/2012

Re: None

Wednesday, 11/01/2017 7:34:23 PM

Wednesday, November 01, 2017 7:34:23 PM

Post# of 40491
Dr. J. Joseph Kim, Inovio's President and Chief Executive Officer, said, “Inovio is successfully executing on its immuno-oncology strategy through both combination and in monotherapy trials

Yet the Share price goes nowhere.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News